Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

BACKGROUND: The use of tacrolimus (TAC) in patients after heart transplantation (HTX) has increased over the last few years. AIM: In this retrospective study, we evaluated the effects of a TAC (conventional and extended-release TAC)-based immunosuppressive therapy regarding rejection profile in comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Helmschrott, Matthias, Beckendorf, Jan, Akyol, Ceylan, Ruhparwar, Arjang, Schmack, Bastian, Erbel, Christian, Gleissner, Christian A, Akhavanpoor, Mohammadreza, Ehlermann, Philipp, Bruckner, Tom, Katus, Hugo A, Doesch, Andreas O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166906/
https://www.ncbi.nlm.nih.gov/pubmed/25246772
http://dx.doi.org/10.2147/DDDT.S68542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166906/
https://www.ncbi.nlm.nih.gov/pubmed/25246772
http://dx.doi.org/10.2147/DDDT.S68542

Ejemplares similares